David M Neville

This inventor holds 22 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 1 EPO patent, primarily in Immunotoxin Technology. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, The United States of America as Represented by the Department of Health, Novartis Ag. Active years: 1982-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David M Neville. Retrieved from https://idiyas.com/inventor/david-m-neville

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 22 (Patent Applications = 4)

% Patents Active = 81.8

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 2.5

ph-index = 10

Forward Citations = 374(Granted Patents)

Company Filing History:

11 out of 3,699

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

7 out of 1,217

The United States of America as Represented by the Department of Health

The UAB Research Foundation (The University of Alabama at Birmingham)

Scott & White Healthcare

patents

7. 1 out of 2,202

The United States of America as Represented by the Secretary of

patents

8. 1 out of 4,249

Wisconsin Alumni Research Foundation

patents

9. 2 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 1982-2021

Loading Chart...

Areas of Expertise:

Immunomodulation

Immunotoxins

Cancer Treatment

Protein Purification

Immune Tolerance

Diphtheria Toxin

Fusion Proteins

Thymus Tolerance

Graft Versus Host Disease

Monoclonal Antibody

Protein Crosslinking

T-lymphocyte

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11098120 - Immunomodulation by anti-CD3 immunotoxins to treat cancers bearing or not uniformly bearing surface CD3 (2021-08-24),

2. 9364557 - Fold-back diabody diphtheria toxin immunotoxin and methods of use (2016-06-14),

3. 8987426 - Immunotoxin fusion proteins and means for expression thereof (2015-03-24),

4. 8921097 - Methods for expression and purification of immunotoxins (2014-12-30),

5. 8217158 - Immunotoxin fusion proteins and means for expression thereof (2012-07-10),

6. 7892786 - Methods for expression and purification of immunotoxins (2011-02-22),

7. 7696338 - Immunotoxin fusion proteins and means for expression thereof (2010-04-13),

8. 7517527 - Immunotoxin with in vivo T cell suppressant activity and methods of use (2009-04-14),

9. 7288254 - Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation (2007-10-30),

10. 7125553 - Methods of inducing immune tolerance using immunotoxins (2006-10-24),

11. 6632928 - Immunotoxins and methods of inducing immune tolerance (2003-10-14),

12. 6103235 - Methods of inducing immune tolerance using immunotoxins (2000-08-15),

13. 5762927 - Thymus tolerance in primates (1998-06-09),

14. 5725857 - Immunotoxin with in vivo T cell suppressant activity and methods of use (1998-03-10),

15. 5167956 - Immunotoxin with in-vivo T cell suppressant activity (1992-12-01),

Title: The Innovative Journey of David M Neville

Introduction:

David M Neville, a distinguished inventor hailing from Bethesda, MD, has made significant contributions to the field of technology and innovation through his groundbreaking inventions and patents.

Latest Patents:

David M Neville's latest patents include cutting-edge technologies in the fields of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach to innovation.

Career Highlights:

With over two decades of experience in the industry, David M Neville has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing solutions that push the boundaries of what is possible. His innovative spirit has led to the creation of several patented technologies that have revolutionized their respective industries.

Collaborations:

Throughout his career, David M Neville has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects, highlighting his strong communication and leadership skills.

Conclusion:

In conclusion, David M Neville's passion for innovation, coupled with his technical expertise and collaborative approach, has cemented his reputation as a trailblazer in the world of inventions. His relentless pursuit of excellence continues to inspire the next generation of inventors and solidify his legacy in the realm of technological advancements.

Profile summary based on public USPTO records.